1175643

Janssen Pharmaceuticals Inc. — FEI 2211100

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 17, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Raritan, NJ (United States)